Holocene Advisors’s Core Laboratories CLB Stock Holding History

Holocene Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,910	Closed	-$295K	–	816
2022 Q2	$295K	Buy	14,910 +2,074	+16%	+$55.1K	﹤0.01%	753
2022 Q1	$406K	Buy	+12,836	New	+$360K	﹤0.01%	778
2021 Q4	–	Sell	-12,786	Closed	-$355K	–	872
2021 Q3	$355K	Buy	+12,786	New	+$389K	﹤0.01%	765
2019 Q3	–	Sell	-28,331	Closed	-$1.48M	–	726
2019 Q2	$1.48M	Buy	+28,331	New	+$1.66M	0.02%	221
2018 Q4	–	Sell	-9,551	Closed	-$1.11M	–	665
2018 Q3	$1.11M	Buy	9,551 +6,637	+228%	+$749K	0.02%	279
2018 Q2	$368K	Buy	+2,914	New	+$355K	0.01%	432
2018 Q1	–	Sell	-4,982	Closed	-$546K	–	567
2017 Q4	$546K	Buy	+4,982	New	+$497K	0.01%	390

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Holocene Advisors's CLB Position: Q3 2022 in Review

Holocene Advisors sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 14,910 shares — an estimated $295K sold.

Holocene Advisors first reported a position in CLB in Q4 2017 and held it in 7 quarters. The position peaked at $1.48M in Q2 2019. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

Holocene Advisors reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
Holocene Advisors sold 14,910 Core Laboratories shares in Q3 2022, an estimated $295K.
Holocene Advisors first reported a position in Core Laboratories in Q4 2017 and held it in 7 quarters.
Holocene Advisors's Core Laboratories position peaked at $1.48M in Q2 2019.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Holocene Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.